GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (BSP:S1RP34) » Definitions » FCF Yield %

Sarepta Therapeutics (BSP:S1RP34) FCF Yield % : -4.07 (As of Dec. 15, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Sarepta Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Sarepta Therapeutics's Trailing 12-Month Free Cash Flow is R$-2,452 Mil, and Market Cap is R$70,990 Mil. Therefore, Sarepta Therapeutics's FCF Yield % for today is -4.07%.

The historical rank and industry rank for Sarepta Therapeutics's FCF Yield % or its related term are showing as below:

BSP:S1RP34' s FCF Yield % Range Over the Past 10 Years
Min: -31.51   Med: -6.19   Max: 3.7
Current: -4.07


During the past 13 years, the highest FCF Yield % of Sarepta Therapeutics was 3.70%. The lowest was -31.51%. And the median was -6.19%.

BSP:S1RP34's FCF Yield % is ranked better than
71.07% of 1507 companies
in the Biotechnology industry
Industry Median: -12.96 vs BSP:S1RP34: -4.07

Sarepta Therapeutics's FCF Margin % for the quarter that ended in Sep. 2024 was -23.11%.


Sarepta Therapeutics FCF Yield % Historical Data

The historical data trend for Sarepta Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics FCF Yield % Chart

Sarepta Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.21 -6.55 -3.28 -6.70

Sarepta Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.62 -3.36 -9.32 -0.36 -3.66

Competitive Comparison of Sarepta Therapeutics's FCF Yield %

For the Biotechnology subindustry, Sarepta Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sarepta Therapeutics's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sarepta Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Sarepta Therapeutics's FCF Yield % falls into.



Sarepta Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Sarepta Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2882.739 / 43041.7344
=-6.70%

Sarepta Therapeutics's annualized FCF Yield % for the quarter that ended in Sep. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-597.872 * 4 / 65317.212
=-3.66%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sarepta Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Sarepta Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sarepta Therapeutics Business Description

Traded in Other Exchanges
Address
215 First Street, Suite 415, Cambridge, MA, USA, 02142
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of company's product candidates are at an early stage of development.

Sarepta Therapeutics Headlines

No Headlines